je.st
news
Pharmaceutical Customers In An Outsourcing Provider Merger -- Part 3 Of Interview With CEO of Newly Formed DPx Holdings B. V.
2014-07-01 16:39:27| drugdiscoveryonline Home Page
“They're so tired of me hammering them on customer metrics. I work on it every week, every site. I tell our workers, ‘You do this, and we'll get you the business.’” -- Jim Mullen This final article in our series featuring Jim Mullen, CEO of newly formed DPx Holdings B. V., discusses how to keep the focus on customers during M&A activity, and the broader transformation of sponsor–provider relationships in the pharmaceutical outsourcing industry. Earlier articles from our interview with Mullen dealt with how an acquisition comes together, and the importance of understanding the relationship between quality, capacity and job security for the early success of any M&A deal. In some ways, we’ve left the most important subject – customers – for last.
Tags: b
v
part
customers
Category:Biotechnology and Pharmaceuticals